Navigation
Welcome to the Vermont Cancer Center's website!
VCC has the national distinction of being designated as one of only 39 comprehensive cancer centers by the National Cancer Institute. VCC's clinical trials serve patients from throughout the New England and upstate New York regions. VCC laboratory-based research projects explore issues in cell signaling and growth control, as well as genome stability and expression, while patient and population-based research focuses on cancer prevention and control.
VCC is dedicated to improving the human condition as it is affected by cancer, through fostering and sustaining innovative research in the laboratory and in the clinic, cancer prevention and control research and programs, state-of-the art cancer diagnosis and treatment, compassionate care that respects the individual patient, education, and community outreach.
Links
The Vermont Cancer Survivor Network's new website is now online!
Parents of two young patients have established The Penelope and Sam Fund for Neuroblastoma Research at VCC.
11th Annual Breast Cancer and Women's Health Conference
High Risk Breast Program
Cancer Patient Support Program
New Interim Director
Posted: 4/9/08
Bernard Levin, MD
Dean Frederick Morin and Dr. Melinda Estes are pleased to announce that Bernard Levin, MD, has agreed to serve as Interim Director of the Vermont Cancer Center. He will begin in early May on a part-time basis, spending several days a week here in Burlington. Dr. Levin will replace Dr. John Fogarty in this role, and we would like to take this opportunity to thank J. for his leadership as interim director during the last 18 months of transition.
Highlights of ASCO 2008
Posted: 4/24/08
Highlights of ASCO 2008
June 20, 2008. Highlights of the American Society of Clinical Oncologists 2008 Annual Meeting. A free program, presented by the Vermont Cancer Center. At the Sheraton Hotel & Conference Center, Burlington, VT.
Neuroblastoma and Medulloblastoma Clinical Trial Opens
Posted: 12/21/07
VCC announces the opening of a Phase II pediatric trial for neuroblastoma and medulloblastoma patients, to examine the treatment effectiveness of Nifurtimox on these types of pediatric cancer. Principal investigator: Giselle Sholler, MD.
[More]
High Risk Breast Program of Vermont
Posted: 12/21/07
We are proud to host the High Risk Breast Program of Vermont's new website. The HRBP is a clinical program with a research focus intended to promote early detection and prevention of breast cancer through screening, treatment, education and research. The HRBP is based within the Breast Care Center and VCC at the University of Vermont and Fletcher Allen Health Care. The HRBP is available to women who have an increased risk for developing breast cancer due to a strong family history of breast and/or ovarian cancer, a genetic abnormality, or prior abnormal breast biopsies.
[More]
News
Posted: 02/20/08
The UVM Men's and Women's basketball teams recently took part in a NCAA nationwide collegiate basketball effort known as Think Pink Day.
[More]
Posted: 02/05/08
The UVM College of Medicine Marathon Team will be running the Keybank Vermont City Marathon on Sunday May 25th in support of The Penelope and Sam Fund for Neuroblastoma Research at the Vermont Cancer Center.
[More]
Posted: 11/13/07
The UVM Men's and Women's basketball teams hosted the Catamount Tip Off on Saturday, October 20th, at Patrick Gym. Team scrimmages and individual skill contests were followed by a special Fan Fest. All ticket proceeds, totaling nearly $1,800 raised, were donated to the VCC in support of breast cancer awareness.
[More]
Posted: 10/01/07
On Thursday, September 20, 2007, Floyd Rourke, long-time friend and supporter of the Vermont Cancer Center passed away at his home near Glens Falls, New York. Rourke, who received an honorary degree from the University of Vermont this May, served as chairman of the board for the Lake Champlain Cancer Research Organization (LCCRO). Over the past 27 years, LCCRO has provided approximately $10 million for VCC scientists, paving the way for such significant breakthroughs as the identification of two colon cancer genes and pioneering sentinel node biopsy, a procedure that reduces the extent and harm of breast cancer surgery.
[More]
Posted: 09/20/07
VCC Member Giselle Sholler, MD, a pediatric oncologist, was interviewed on Vermont Public Radio on September 19, 2007. Click here to hear her speak about her groundbreaking neuroblastoma research.
[More]
Posted: 08/29/07
We are pleased to announce the appointment of Kimberly P. Luebbers, RN, BSN, OCN, MT(ASCP), as Administrative Director of the Vermont Cancer Center, following a national search.
[More]
Posted: 06/28/07
As Leon Strader checks in at the counter of the Hem/Onc clinic at the Vermont Cancer Center at UVM/Fletcher Allen, he takes on more than just the role of a patient showing up for weekly chemo. He is also one of the thousands of patients across the country who advance the cause of medical science by helping to test new treatments as participants in a clinical trial....
[More]
Posted: 06/27/07
New Position Integrates Cancer Care and Clinical Research at UVM and Fletcher Allen.
[More]
Posted: 06/27/07
Berta Geller Receives Two-Year Grant. The ACS announced that it has awarded a $213,500 scholar grant to support ongoing VCC research aimed at improving skills for radiologists who read mammograms.
[More]
Posted: 05/21/07
Lake Champlain Cancer Research Organization (LCCRO) board chairman Floyd H. Rourke received an honorary degree during the University of Vermont's 203rd commencement ceremony on Sunday, May 20.
[More]
Posted: 04/12/07
The Vermont Cancer Center now has a toll-free phone number which will serve as the primary contact line for all external VCC calls including: patient questions, patient referrals, and all other cancer-related calls. 1-877-540-HOPE.
[More]